VOYAGER THERAPEUTICS INC. - COMMON STOCK
7.5400
18-April-24 14:59:59
15 minutes delayed
Stocks
-0.2000
-2.58%
Today's range
7.5100 - 7.8800
ISIN
N/A
Source
NASDAQ
-
16 Apr 2024 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
26 Mar 2024 15:01:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
13 Mar 2024 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
28 Feb 2024 15:01:00 By Nasdaq GlobeNewswire
-
26 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
21 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
20 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics to Present at the Oppenheimer Annual Life Sciences Conference
07 Feb 2024 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Pricing of Public Offering
04 Jan 2024 21:45:43 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Proposed Public Offering
04 Jan 2024 15:14:15 By Nasdaq GlobeNewswire
-
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
02 Jan 2024 06:00:00 By Nasdaq GlobeNewswire
-
06 Dec 2023 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results
06 Nov 2023 15:01:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Third Quarter 2023 Conference Call and Webcast
30 Oct 2023 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics to Present at the Chardan Genetic Medicines Conference
25 Sep 2023 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Sep 2023 15:01:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics to Participate in Upcoming Investor Conferences
30 Aug 2023 06:00:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08 Aug 2023 15:01:00 By Nasdaq GlobeNewswire
-
Voyager Therapeutics Announces Appointment of Beth Shafer as Chief Business Officer
07 Aug 2023 07:00:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >